Eyal Rubin's Net Worth

$859 Thousand

Estimate Recalculated Apr 25, 2024 03:03PM EST

Who is Eyal Rubin?

Eyal Rubin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BRAINSTORM CELL THERAPEUTICS INC., and Protalix BioTherapeutics, Inc..

SEC CIK

Eyal Rubin's CIK is 0001721411

Past Insider Trading and Trends

2017 was Eyal Rubin's most active year for acquiring shares with 2 total transactions. Eyal Rubin's most active month to acquire stocks was the month of July. 2019 saw Eyal Rubin paying a total of $0.00 for 800,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.3849

CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Nov 20
Form 3
—
0
—
—
0
No matching records found

Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.49

Sr. VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+54.85%
201.9K
—
—
570K
Aug 15
Form 4
—
0
—
—
0
Sep 7
Form 4
+49.54%
121.95K
—
—
368.1K
Feb 25
Form 4/A
∞
246.15K
—
—
246.15K
Aug 11
Form 4
∞
246.15K
—
—
246.15K
Aug 11
Form 4
—
0
—
—
0
Sep 22
Form 3
—
0
—
—
0
No matching records found